Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

24 April 2011

Palliative first-line therapy with weekly high-dose 5-fluorouracil and sodium folinic acid as a 24-hour infusion (AIO regimen) combined with weekly irinotecan in patients with metastatic adenocarcinoma of the stomach or esophagogastric junction followed by secondary metastatic resection after downsizing

Kathrin Koucky ABCDEF , Axel Wein ABCDEFG , Peter C. Konturek DE , Heinz Albrecht B , Udo Reulbach CD , Gudrun Mannlein E , Kerstin Wolff B , Nicola Ostermeier B , Dagmar Busse B , Henriette Golcher D , Claus Schildberg D , Rolf Janka B , Werner Hohenberger DE , Eckhart G. Hahn D , Jurgen Siebler DE , Markus F. Neurath D , Frank Boxberger ABCDEFG

DOI: 10.12659/MSM.881764

Med Sci Monit 2011; 17(5): CR248-258

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750